Women Don't Age in Departments

There is a sentence I keep coming back to: women don't age in departments. It sounds simple, but most of how we talk about — and treat — women's health assumes the opposite.

The silo problem

Consider how a woman typically encounters her own health information. She learns about her cycle through fertility tracking. She hears about bone density for the first time when someone mentions osteoporosis. She learns about cardiovascular risk in a different conversation, mood in another, skin in another, cognition in yet another. Each is treated as a separate domain with its own timeline and its own intervention.

This is not how the body works. These systems are connected, and for women the connections run through endocrine signaling that changes over the life course in ways that are not mirrored in men.

Ovarian aging as a system event

The clearest example is ovarian aging. The decline in ovarian function is not solely a reproductive matter. The hormonal signaling that changes as the ovary winds down its activity intersects with bone, cardiovascular, metabolic, neurological and musculoskeletal systems. The years around the menopausal transition are associated with measurable changes across many of these — bone loss accelerates, cardiovascular risk profile shifts, body composition changes, sleep and mood patterns shift.

The point is not that menopause causes everything. It is that a single endocrine event has system-wide reverberations. If you only look at the department where a symptom shows up, you miss the upstream cause and you miss the opportunity to act earlier.

Healthspan, not just lifespan

There is a useful distinction growing in longevity science: lifespan is how long you live; healthspan is how long you live well. For women, who on average live longer than men but spend a larger share of later life in poorer health, the healthspan gap is the real problem. Closing it is not about one miracle intervention. It is about supporting the underlying systems — metabolic, musculoskeletal, hormonal, cognitive — so that the later decades are not just longer but more functional.

This is where the systems view earns its keep. A department-by-department approach reacts to failure. A systems approach tries to maintain reserve across the connected networks before failure arrives.

What the evidence supports

I want to be careful here, because women's health is a field full of confident claims and thin evidence. Here is what I think the evidence supports, without overclaiming:

• Ovarian reserve is real and finite. Markers like anti-Müllerian hormone (AMH) and antral follicle count track a declining resource. They are useful for understanding trajectory, not for panicking about a single number.
• The perimenopausal transition is a system event. Its effects reach beyond reproduction, and the years around it are a window where proactive support — in bone health, metabolic health, strength, sleep — can pay off for decades.
• Muscle and bone are not vanity. Skeletal muscle and bone mass are among the most actionable reserves a woman can build. Resistance training and adequate protein are some of the best-evidenced, least-glamorous interventions for long-term female healthspan.
• Most "anti-aging" products are not aging science. The commercial conversation is crowded. The scientific conversation is more cautious. Treat most of it as marketing until you have read the underlying work.

The principle behind Female Reserve

This is the principle the company is built on: understand the system, monitor the reserves, act early, and resist the silo. We don't believe women need another single-purpose product for one department. We believe they need a way to see the whole system and protect the reserves that run through it.

Women don't age in departments. Neither should the way we care for them.

---

Selected references & further reading

This is not a medical paper, but the ideas above are grounded in real work. A few sources worth reading:

• American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and Sterility.
• te Velde ER, Pearson PL. The variability of female reproductive ageing. Human Reproduction Update, 2002.
• National Institute on Aging (NIA), NIH — resources on menopause and the healthspan/lifespan distinction.
• Study of Women's Health Across the Nation (SWAN), NIH — longitudinal data on the menopausal transition and its system-wide effects.
• American College of Obstetricians and Gynecologists (ACOG) — clinical guidance on the perimenopausal transition and bone health.